New frontier of metastatic breast cancer treatment and cardiotoxicity: the result after one year of therapy with Trastuzumab-Deruxtecan

Scritto il 07/03/2025
da M. Iacono, L.M. Capece, M. Pontoriero, D. Paoletta, P. Megaro, E. Luise, V. Gammaldi, M. Pucci, R. Esposito (Napoli)